These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2402224)
1. Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol. Bornheim LM; Correia MA Mol Pharmacol; 1990 Sep; 38(3):319-26. PubMed ID: 2402224 [TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol. Bornheim LM; Correia MA Mol Pharmacol; 1989 Sep; 36(3):377-83. PubMed ID: 2779523 [TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome P-450IIC subfamily. Bornheim LM; Correia MA Mol Pharmacol; 1991 Aug; 40(2):228-34. PubMed ID: 1875910 [TBL] [Abstract][Full Text] [Related]
4. Effect of cannabidiol on cytochrome P-450 isozymes. Bornheim LM; Correia MA Biochem Pharmacol; 1989 Sep; 38(17):2789-94. PubMed ID: 2550010 [TBL] [Abstract][Full Text] [Related]
5. Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver. Narimatsu S; Watanabe K; Yamamoto I; Yoshimura H Drug Metab Dispos; 1988; 16(6):880-9. PubMed ID: 2907469 [TBL] [Abstract][Full Text] [Related]
6. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Pichard L; Gillet G; Fabre I; Dalet-Beluche I; Bonfils C; Thenot JP; Maurel P Drug Metab Dispos; 1990; 18(5):711-9. PubMed ID: 1981725 [TBL] [Abstract][Full Text] [Related]
7. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs. Stevens JC; Halpert J Mol Pharmacol; 1988 Jan; 33(1):103-10. PubMed ID: 3336347 [TBL] [Abstract][Full Text] [Related]
8. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase. Ng SF; Waxman DJ Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156 [TBL] [Abstract][Full Text] [Related]
9. Effects of a series of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver. Riddick DS; Park SS; Gelboin HV; Marks GS Mol Pharmacol; 1989 May; 35(5):626-34. PubMed ID: 2725472 [TBL] [Abstract][Full Text] [Related]
10. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat. List A; Nazar B; Nyquist S; Harclerode J Drug Metab Dispos; 1977; 5(3):268-72. PubMed ID: 17525 [TBL] [Abstract][Full Text] [Related]
11. Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene. Cresteil T; Beaune P; Celier C; Leroux JP; Guengerich FP J Pharmacol Exp Ther; 1986 Jan; 236(1):269-76. PubMed ID: 3941398 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation. Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124 [TBL] [Abstract][Full Text] [Related]
13. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6. Ohmori S; Shirakawa C; Motohashi K; Yoshida H; Abe H; Nakamura T; Horie T; Kitagawa H; Asaoka K; Rikihisa T Mol Pharmacol; 1993 Feb; 43(2):183-90. PubMed ID: 8429823 [TBL] [Abstract][Full Text] [Related]
14. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450. Ciaccio PJ; Duignan DB; Halpert JR Drug Metab Dispos; 1987; 15(6):852-6. PubMed ID: 2893713 [TBL] [Abstract][Full Text] [Related]
15. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite. Cook CS; Hauswald C; Oppermann JA; Schoenhard GL J Pharmacol Exp Ther; 1993 Jul; 266(1):1-7. PubMed ID: 8331551 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a PCN-P450 enzyme in chickens and comparison of its development with that of other phenobarbital-inducible forms. Lorr NA; Bloom SE; Park SS; Gelboin HV; Miller H; Friedman FK Mol Pharmacol; 1989 May; 35(5):610-6. PubMed ID: 2725470 [TBL] [Abstract][Full Text] [Related]
17. Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo. Halpert J; Balfour C; Miller NE; Morgan ET; Dunbar D; Kaminsky LS Mol Pharmacol; 1985 Sep; 28(3):290-6. PubMed ID: 4033629 [TBL] [Abstract][Full Text] [Related]
18. Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver. Craig PI; Mehta I; Murray M; McDonald D; Aström A; van der Meide PH; Farrell GC Mol Pharmacol; 1990 Sep; 38(3):313-8. PubMed ID: 1698250 [TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450-dependent monooxygenase activities and their inducibility by classic P450 inducers in the liver, kidney, and nasal mucosa of male adult ring-necked pheasants. Giorgi M; Marini S; Longo V; Mazzaccaro A; Amato G; Gervasi PG Toxicol Appl Pharmacol; 2000 Sep; 167(3):237-45. PubMed ID: 10986015 [TBL] [Abstract][Full Text] [Related]
20. Participation of P450 3A enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation. Martini R; Murray M Arch Biochem Biophys; 1993 May; 303(1):57-66. PubMed ID: 8489266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]